Treatment of severe hyponatremia

Kidney International

Volumn 60, Issue 6, 2001, Pages 2417-2427

  Gross, Peter ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Aquaporins; Aquaresis; Blood brain barrier; Central pontine myelinolysis; Cerebral edema; Porphyria; Vasopressin antagonists

Indexed keywords

CIMETIDINE; GLUCOSE; GONADORELIN; METOLAZONE; PETHIDINE; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; VASOPRESSIN ANTAGONIST;

ACUTE INTERMITTENT PORPHYRIA; BLOOD PRESSURE; BRAIN EDEMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; GASTROSCOPY; GLUCOSE INFUSION; GRAND MAL SEIZURE; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; LABORATORY TEST; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULSE RATE; REVIEW; SODIUM BLOOD LEVEL; SYMPTOMATOLOGY; TEMPERATURE;

EID: 0035177051     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00063.x     Document Type: Article

References (85)

1. Acute intermittent porphyria
2. The acute porphyrias
3. Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis
4. Acute intermittent porphyria: Clinicopathologic correlation
5. V2-vasopressin receptor antagonists - Mechanism of effect and clinical implications in hyponatraemia
6. The treatment of severe hyponatremia
7. Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes
8. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy
9. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women
10. Pathogenesis and prevention of hyponatremic encephalopathy
11. Long-term neurological outcome in psychogenic water drinkers with severe symptomatic hyponatremia: The effect of rapid correction
12. Severe diuretic-induced hyponatremia in the elderly. A series of eight patients
13. Oral water intoxication in infants
14. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners
15. Hyponatraemia and death or permanent brain damage in healthy children
16. Endometrial ablation complicated by fatal hyponatremic encephalopathy
17. Postoperative hyponatremic encephalopathy in menstruant women
18. Pulmonary complications of hyponatremic encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure
19. Chronic hyponatremic encephalopathy in postmenopausal women. Association of therapies with morbidity and mortality
20. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study
21. Management of hyponatremic seizures in children with hypertonic saline: A safe and effective strategy
22. Management of hyponatraemia
23. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution
24. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
25. The diversity of volume regulatory mechanisms
26. Sex differences result in increased morbidity from hyponatremia in female rats
27. Age, gender, and vasopressin affect survival and brain adaptation in rats with metabolic encephalopathy
28. Hormonal dependence of the effects of metabolic encephalopathy on cerebral perfusion and oxygen utilization in the rat
29. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study
30. Adaptation to acute and chronic hyponatremia: Implications for symptomatology, diagnosis, and therapy
31. Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals
32. Symptomatic hyponatremia in rats: Effect of treatment on mortality and brain lesions
33. Inappropriate secretion of antidiuretic hormone, polydipsia and hypothalamic calcifications
34. Osmotic demyelination syndrome following correction of hyponatremia
35. Severe symptomatic hyponatremia: Treatment and outcome. A study of 64 cases
36. Association between rise in serum sodium and central pontine myelinolysis
37. Central pontine myelinolysis
38. Central pontine myelinolysis: Clinical presentation and radiologic findings
39. Central pontine myelinolysis after liver transplantation
40. Neurologic sequelae after treatment of severe hyponatremia: A multicenter perspective
41. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: A prospective magnetic resonance imaging study
42. Symptomatic hyponatraemia: Can myelinolysis be prevented by treatment?
43. Determinants of brain myelinolysis following correction of chronic hyponatremia in rats
44. Role of organic osmolytes in myelinolysis
45. Adaptive decreases in amino acids (taurine in particular), creatinine, and electrolytes prevent cerebral edema in chronically hyponatremic mice: Rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain
46. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia
47. Rapid correction of hyponatremia produces differential effects on brain osmolyte and electrolyte reaccumulation in rats
48. Brain adaptation to hyponatremia: Physiological mechanisms and clinical implications
49. Mechanisms of osmolyte release
50. Introduction to cell volume regulatory mechanisms
51. Raised intracranial pressure, oedema, hydrocephalus
52. Hyperosmolar blood-brain barrier disruption in baboons: An in vivo study using positron emission tomography and rubidium-82
53. Outwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other means
54. Electrolyte-induced demyelination in rats. Role of the blood-brain barrier and edema
55. Electrolyte-induced demyelination in rats. Ultrastructural evolution
56. Prevention of myelinolysis in rats by dexamethasone or colchicine
57. Protective effect of steroids in electrolyte-induced demyelination
58. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatremic rats treated with hypertonic saline or urea: Advantages of urea
59. Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients
60. Characterization of SR 121463A, a highly potent selective, orally active vasopressin V2-receptor antagonist
61. Role of vasopressin in abnormal water excretion in cirrhotic patients
62. Upregulation of aquaporin-2 water channel expression in congestive heart failure rat
63. Effect of long-term treatment with selective vasopressin V1 and V2 receptor antagonist on the development of heart failure in rats
64. Effect of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs
65. Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats
66. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis
67. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats
68. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats
69. Acute aquaresis by the nonpep-tide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
70. Psychogenic polydipsia with hyponatremia: Report of eleven cases
71. Hypouricemia in chronic schizophrenic patients with polydipsia and hyponatremia
72. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia
73. Polydipsia and hyponatremia in psychiatric patients
74. The syndrome of self-induced water intoxication in psychiatric patients
75. Hyponatremia in psychogenic polydipsia
76. Cortical laminar necrosis and central pontine myelinolysis in a patient with Sheehan syndrome and severe hyponatremia
77. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms
78. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients
79. Beer potomania: Two cases and review of the literature
80. Effects of DDAVP and AVP on sodium and water balance in conscious rats
81. Mechanisms of escape from desmopressin in the rat
82. Clinicopathology of kidneys from brain-dead patients treated with vasopressin and epinephrine
83. Diabetes insipidus in neurosurgical patients
84. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: Effect of correction of donor hypernatremia
85. Brain damage and postoperative hyponatremia: The role of gender